Suppression of Vascular Endothelial Growth Factor (VEGF) Expression by Targeting the Bcr-Abl Oncogene and Protein Tyrosine Kinase Activity in Bcr-Abl-positive Leukaemia Cells

Author： Li L   Zhang R   Fang ZY   Chen JN   Zhu ZL  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.37, Iss.2, 2009-03, pp. : 426-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are there better Bcr-Abl kinase inhibitors for chronic myeloid leukaemia than imatinib?

By Doggrell Sheila A   Christensen Anne-Marie  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 157-163

Informa Healthcare

Access to resources Recommend Favorite

Enhancement of Imatinib-Induced Apoptosis by Matrine in bcr/abl-Positive Leukemia K562 Cells

By Liu Xiao-Shan   Jiang JiKai  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 44, Iss. 4, 2006-06 ,pp. : 287-291

Informa Healthcare

Access to resources Recommend Favorite

Combination of intensive chemotherapy and imatinib can produce complete remission in patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukaemia

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms

By  

Current Medicinal Chemistry, Vol. 17, Iss. 13, 2010-05 ,pp. : 1220-1245

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in treatment of chronic myeloid leukemia with tyrosine kinase inhibitors: the evolving role of Bcr–Abl mutations and mutational analysis

By Soverini Simona   Martinelli Giovanni   Rosti Gianantonio   Iacobucci Ilaria   Baccarani Michele  

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1271-1284

Future Medicine

Access to resources Recommend Favorite